Startups

Absci shares spike 30% in IPO debut, valuing Washington state biotech company at nearly $2B


Shares of Absci surged more than 30% on Thursday as the Vancouver, Wash.-based biotech company made its debut as a public company. Absci priced its …

Read more @ www.geekwire.com

Back to top button